12
views
0
recommends
+1 Recommend
2 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      The case for relaxing no-visitor policies in hospitals during the ongoing COVID-19 pandemic

      article-commentary
      , MD , , MD, , MD MSc
      CMAJ : Canadian Medical Association Journal
      Joule Inc.

      Read this article at

      ScienceOpenPublisherPMC
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          KEY POINTS Restrictive “no-visitor” policies were adopted in Canada during the first wave of the pandemic in an attempt to mitigate introduction and spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) within hospitals, and to preserve personal protective equipment (PPE) for health workers. Available literature does not support a substantial role for family members and designated support persons in the transmission of SARS-CoV-2 in hospitals. Extensive evidence has shown that family members or designated support persons are important in the delivery of patient-centred care, particularly for patient advocacy, feeding, mobility, orientation, emotional support in settings of delirium, cognitive impairment, language barriers, end-of-life care, labour and delivery, and transitions to critical care. We argue that in the current wave of the coronavirus disease 2019 (COVID-19) pandemic, hospitals should adopt more accommodating visitor policies with careful use of PPE and monitoring, paying careful attention to community prevalence of COVID-19 and, in the future, immunization status. In an attempt to mitigate excess transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Canadian hospitals adopted “no visitor” policies during the first wave of the pandemic. A reflexive and almost complete restriction of visitors occurred across all hospitals surveyed in a pan-Canadian study involving 35 hospitals.1 Such policies were designed to balance the interests of patients and their caregivers against society’s utilitarian responsibility to mitigate transmission into and within hospitals, with the secondary objective of preserving personal protective equipment (PPE) when concerns existed surrounding its supply. In the midst of a second wave, it is prudent to consider whether visitor restrictions should be kept stringent to fulfill infection prevention and control (IPAC) concerns and the precautionary principle, or whether they should be relaxed to mitigate harms to patients and families. Visitor restrictions in hospitals are not unique to the coronavirus disease 2019 (COVID-19) pandemic and have existed for many decades. Lessons learned from seasonal influenza suggest that preventing outbreaks of respiratory viruses in the acute care hospital sector is vital to ensure that hospitals can provide needed care for all.2 However, a progressive relaxation of hospital rules for visitors began after mounting evidence of the beneficial effect of family or designated support persons being present for patients admitted to hospital.3,4 Before the COVID-19 pandemic, a systematic review that evaluated liberal versus restrictive visitation policies in adult intensive care unit (ICU) settings found no increase in acquired infections or septic complications with more liberal visitation policies.3 A 2020 review (before the pandemic) found that 73% of hospitals had adopted accommodating visitation policies compared with only 32% in 2015.1 At present there is limited evidence to support visitors having an important role in hospital-related transmission of COVID-19. Early in the pandemic, before the widespread implementation of public health and IPAC measures, a systematic review of nosocomial acquisitions of COVID-19 from case series in Wuhan, China, reported that only 2% were from people other than medical staff (e.g., visitors).5 A more recent study of 9149 patients admitted to hospital in the United States from Mar. 7 to May 30, 2020, found low rates of hospital-acquired COVID-19.6 Only 1.7% (12/697) of patients with COVID-19 were defined as having a positive test result 3 days after admission or within 14 days of discharge and 10 of the 12 were most likely late identification of community-acquired cases. Only 1 was deemed to be acquired from a presymptomatic visitor before restrictions were implemented. The low rates cannot be attributable solely to visitor restrictions because restriction policies were implemented at the midpoint of this study time period. Widespread, indiscriminate policies restricting visitors are associated with multiple risks for patients, families and health care providers.3,4,7–10 Although the term visitors generally includes any person who has a relationship with a patient, it is important to distinguish general visitors from “family” or “designated support persons” (also known as care partners). Family or designated care partners are increasingly recognized as being key to the delivery of patient-centred care (e.g., assisting with feeding, mobility, hygiene, orientation, emotional support). Accommodating visitation policies have been shown to improve communication and build trust between families and care providers, especially when patients do not speak the same language as their health care workers.7 Family members are essential in communication about escalation of care in the event a patient is incapable and often act as patient advocates. Preliminary research has suggested that delirium is common among acute and critically ill patients with COVID-19.8 Patients with delirium have longer hospital stays and increased risk of death. In the ICU setting, family participation and flexible visitor policies have been shown to be associated with reduced delirium and improved longer-term psychologic recovery.3 In general, family-centred care interventions have shown decreased ICU length of stay and improved patient experience and patient and family mental health.4 A recent observational study evaluated the effect of visitor restrictions on postoperative experiences of patients undergoing surgery during the COVID-19 pandemic.9 Patients exposed to visitor restrictions had delays in receiving medications, greater social isolation, difficulty in getting out of bed and were more likely to not have their discharge preferences adequately considered compared with patients who did not have restrictions on visitors before visitor restriction policies were initiated. Data are limited regarding the impact of restrictive visitation policies on families. However, a 2017 observational study found that a dying patient’s inability to say goodbye to their family was associated with complicated grief for the family.10 Dying alone is distressing and confusing for patients and psychologically distressing for loved ones. Health care workers have reported substantial distress associated with being a “placeholder” for families at the end of life.11 Participants in a study of health care providers across ICUs in France from April to May 2020 expressed deep regret and symptoms of anxiety or depression about the COVID-19 visitor restrictions.12 How can we balance these risks as the pandemic continues? To ensure adequate IPAC measures as the community prevalence of COVID-19 rises, some restrictions will be needed. Higher visitor numbers will increase challenges to maintaining adequate physical distancing (e.g., in elevators and entrances). Nosocomial outbreaks have been seen in both waves of the pandemic in Canada. Some may have originated from asymptomatic health care workers infected in the community using shared spaces for breaks and meals, whereas others could have originated from asymptomatic visitors without sufficient education in PPE use or who did not articulate symptoms on entry screening. In the second wave of the pandemic, many institutions in Canada have begun to adopt a less restrictive policy that recognizes the importance of family and care partners after reflecting on their experiences in the first wave. For example, some institutional contexts that should make exceptions for family members or designated care partners include hospices and palliative care, ICUs, labour and delivery suites, and surgical recovery wards. Patients transitioning to critical or end-of-life care, as well as patients with delirium, cognitive impairment, language barriers or severe psychiatric conditions, could also benefit from relaxed visitation policies. How different visitation policies affect the risk of acquiring COVID-19 is unknown. Community prevalence of infection, including rate of asymptomatic infection, mode of transmission and quality of contact tracing, will affect rates of transmission to a hospital setting. However, rigorous IPAC measures (e.g., masks, handwashing and screening upon hospital arrival) and a well-performing, rapid COVID-19 test could mitigate the risk of transmission substantially. Data are needed to better determine the balance between these competing factors. The substantial between-jurisdiction variation in prevalence of COVID-19 means that risks should be assessed at the regional or hospital level and visitation policies tailored accordingly. Steps to reduce transmission risk include enhanced visitor screening and education, limiting visitors to a specified number of family members or designated care partners per patient, limiting the duration of the visit, selected use of point-of-care testing (if available), contact tracing by the region (if feasible) and ensuring appropriate PPE for visitors. Safe visitation is anchored on visitors accurately and honestly reporting their symptoms, and their availability and compliance with PPE. A 2018 survey of visitors to patients with Clostridium difficile infection found that nurses are fundamental in educating visitors in the effective use of PPE.13 There may be a need for additional staffing and visitor education to ensure appropriate use of PPE. Given the greater challenges of ensuring appropriate PPE use for those visiting patients with COVID-19, tighter restrictions on visitation may be required for this subgroup of patients. If visitors must be kept away, easy access to video conferencing can reduce the risks associated with patient isolation. A study that evaluated the feasibility and acceptability of e-communication for palliative care family meetings during the pandemic found that video conferencing was scheduled successfully across 97% of cases, and 80% of family members felt comfortable articulating questions and expressing thoughts throughout the meeting.14 However, video conferencing requires access to devices and facilitation by health care staff, increasing their work load. It does not allow for impromptu conversations, is often challenging when escalation or end-of-life care must be discussed, and it is not clear that patient information is being shared only with people that the patient would consent to involving in such discussions. Furthermore, the use of mobile communication could be associated with fomite transmission, and, therefore, IPAC measures should guide disinfection of these devices.15 Where feasible, some centres have used outdoor spaces to facilitate visits between patients and families. The existing literature does not support any scenario where a complete restriction of visitors across all patient subtypes from hospitals is required. Although the evidence is not conclusive, we believe that restrictive visitor policies may do more harm than good in specific settings, and there are specific circumstances where hospital visitation policies should be relaxed with careful use of PPE and monitoring, paying careful attention to community prevalence of COVID-19 and community immunization status in the future. A Canadian study is currently underway to evaluate the pandemic’s impact on visitation policies across Canadian hospitals (https://cumming.ucalgary.ca/research/calgary-critical-care-research-network/research/COVID-19).

          Related collections

          Most cited references15

          • Record: found
          • Abstract: found
          • Article: found
          Is Open Access

          Delirium and encephalopathy in severe COVID-19: a cohort analysis of ICU patients

          Background Neurotropism of SARS-CoV-2 and its neurological manifestations have now been confirmed. We aimed at describing delirium and neurological symptoms of COVID-19 in ICU patients. Methods We conducted a bicentric cohort study in two French ICUs of Strasbourg University Hospital. All the 150 patients referred for acute respiratory distress syndrome due to SARS-CoV-2 between March 3 and May 5, 2020, were included at their admission. Ten patients (6.7%) were excluded because they remained under neuromuscular blockers during their entire ICU stay. Neurological examination, including CAM-ICU, and cerebrospinal fluid analysis, electroencephalography, and magnetic resonance imaging (MRI) were performed in some of the patients with delirium and/or abnormal neurological examination. The primary endpoint was to describe the incidence of delirium and/or abnormal neurological examination. The secondary endpoints were to describe the characteristics of delirium, to compare the duration of invasive mechanical ventilation and ICU length of stay in patients with and without delirium and/or abnormal neurological symptoms. Results The 140 patients were aged in median of 62 [IQR 52; 70] years old, with a median SAPSII of 49 [IQR 37; 64] points. Neurological examination was normal in 22 patients (15.7%). One hundred eighteen patients (84.3%) developed a delirium with a combination of acute attention, awareness, and cognition disturbances. Eighty-eight patients (69.3%) presented an unexpected state of agitation despite high infusion rates of sedative treatments and neuroleptics, and 89 (63.6%) patients had corticospinal tract signs. Brain MRI performed in 28 patients demonstrated enhancement of subarachnoid spaces in 17/28 patients (60.7%), intraparenchymal, predominantly white matter abnormalities in 8 patients, and perfusion abnormalities in 17/26 patients (65.4%). The 42 electroencephalograms mostly revealed unspecific abnormalities or diffuse, especially bifrontal, slow activity. Cerebrospinal fluid examination revealed inflammatory disturbances in 18/28 patients, including oligoclonal bands with mirror pattern and elevated IL-6. The CSF RT-PCR SARS-CoV-2 was positive in one patient. The delirium/neurological symptoms in COVID-19 patients were responsible for longer mechanical ventilation compared to the patients without delirium/neurological symptoms. Delirium/neurological symptoms could be secondary to systemic inflammatory reaction to SARS-CoV-2. Conclusions and relevance Delirium/neurological symptoms in COVID-19 patients are a major issue in ICUs, especially in the context of insufficient human and material resources. Trial registration NA.
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            Symptoms of Anxiety, Depression, and Peritraumatic Dissociation in Critical Care Clinicians Managing Patients with COVID-19. A Cross-Sectional Study

            Rationale: Frontline healthcare providers (HCPs) during the coronavirus disease (COVID-19) pandemic are at high risk of mental morbidity. Objectives: To assess the prevalence of symptoms of anxiety, depression, and peritraumatic dissociation in HCPs. Methods: This was a cross-sectional study in 21 ICUs in France between April 20, 2020, and May 21, 2020. The Hospital Anxiety and Depression Scale and the Peritraumatic Dissociative Experience Questionnaire were used. Factors independently associated with reported symptoms of mental health disorders were identified. Measurements and Main Results: The response rate was 67%, with 1,058 respondents (median age 33 yr; 71% women; 68% nursing staff). The prevalence of symptoms of anxiety, depression, and peritraumatic dissociation was 50.4%, 30.4%, and 32%, respectively, with the highest rates in nurses. By multivariable analysis, male sex was independently associated with lower prevalence of symptoms of anxiety, depression, and peritraumatic dissociation (odds ratio of 0.58 [95% confidence interval, 0.42–0.79], 0.57 [95% confidence interval, 0.39–0.82], and 0.49 [95% confidence interval, 0.34–0.72], respectively). HCPs working in non–university-affiliated hospitals and nursing assistants were at high risk of symptoms of anxiety and peritraumatic dissociation. Importantly, we identified the following six modifiable determinants of symptoms of mental health disorders: fear of being infected, inability to rest, inability to care for family, struggling with difficult emotions, regret about the restrictions in visitation policies, and witnessing hasty end-of-life decisions. Conclusions: HCPs experience high levels of psychological burden during the COVID-19 pandemic. Hospitals, ICU directors, and ICU staff must devise strategies to overcome the modifiable determinants of adverse mental illness symptoms.
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              Incidence of Nosocomial COVID-19 in Patients Hospitalized at a Large US Academic Medical Center

              This cohort study evaluates the incidence of nosocomial coronavirus disease 2019 (COVID-19) among patients admitted to a US medical center in the context of a comprehensive and progressive infection control program.

                Author and article information

                Journal
                CMAJ
                CMAJ
                9711805
                CMAJ : Canadian Medical Association Journal
                Joule Inc.
                0820-3946
                1488-2329
                25 January 2021
                18 December 2020
                : 193
                : 4
                : E135-E137
                Affiliations
                Interdepartmental Division of Critical Care Medicine, Department of Medicine (Munshi), Sinai Health System and University Health Network, University of Toronto; Institute of Health Policy, Management and Evaluation (Munshi, Razak), University of Toronto, Toronto, Ont.; Ontario COVID-19 Science Advisory Table (Munshi, Evans, Razak); Division of Infectious Disease, Department of Medicine (Evans), Kingston Health Sciences Centre, Queen’s University, Kingston, Ont.; Department of Medicine (Razak), St. Michael’s Hospital, Unity Health; Division of General Internal Medicine, Department of Medicine (Razak), University of Toronto; Li Ka Shing Knowledge Institute (Razak), St. Michael’s Hospital, Toronto, Ont.
                Author notes
                Correspondence to: Laveena Munshi, Laveena.munshi@ 123456sinaihealth.ca
                Article
                193e135
                10.1503/cmaj.202636
                7954559
                33355198
                c828b9b7-a61a-4f45-84f5-e5498fc2729e
                © 2021 Joule Inc. or its licensors

                This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY-NC-ND 4.0) license, which permits use, distribution and reproduction in any medium, provided that the original publication is properly cited, the use is noncommercial (i.e. research or educational use), and no modifications or adaptations are made. See: https://creativecommons.org/licenses/by-nc-nd/4.0/

                History
                Categories
                Commentary
                Health Services

                Comments

                Comment on this article

                Related Documents Log